It is a support menu from here.
Main Menu
Hokunalin® Tape
The Hokunalin® Tape jointly developed in
1988 by Abbott Japan Co., Ltd and Nitto Denko was
the world's first transdermal patch for treatment
of asthma. The adhesive layer of the tape contains
tulobuterol, a drug that dilates the bronchial
tubes making it easier for asthma sufferers to
breathe. When the patch is applied to the skin,
the drug penetrates the skin and is absorbed into
the blood stream through the capillaries to flow
throughout the body. This is in effect the same
as using an injection, but without requiring the
use of a needle.
Unlike conventional oral and inhaled
formulations, Hokunalin® Tape has the advantage
of being able to appropriately control the concentration
of the drug in the body. This means that users
can control asthma attacks, which frequently occur
in the early morning, and that the burden on caregivers
is also greatly reduced.
The development of these patches, however,
took 11 years and was full of challenges.
Designing transdermal patches is one area in which Nitto Denko has a great deal of expertise. By 1983 we had already developed a transdermal patch for preventing the onset of angina.
The mechanism whereby drugs are delivered to the body through the transdermal patch.
With conventional transdermal formulations, drugs
were continuously in the body for long periods
of time. The developers wanted to develop a more
advanced product that was able to deliver the required
drug dosage at the right time for use in the treatment
of asthma.
In many cases, asthma attacks occur
at set times, such as in the early morning. If
a drug delivery system could be developed that
was able to deliver the optimum amount of medication
at that time (a smart drug delivery system), then
it would be possible to dramatically increase the
quality of life of asthma sufferers.
In order to realize this goal, however,
it is necessary to achieve precision control of
drug release speed. This proved to be extremely
difficult.
A typical scene showing the kind of experiments that were repeatedly carried out during development.
Drug release speed is determined by the complex
relationships between the type of adhesive used,
the thickness of the adhesive coating, and the
content and concentration of drug contained in
the adhesive. Moreover, the type of adhesive that
can be used in medical applications is also limited,
which means that inevitably it is necessary to
control release speed using drug content and concentration.
In the absence of any revolutionary
way of solving this problem, it was a matter of
making samples with various combinations in a process
of trial and error. Although computer simulations
can now be used for parts of this process, at that
particular time there was no such convenience.
It was a case of trying every combination and investigating
each individual possibility.
Eventually, as a result of many years
of painstaking hard work, this goal was achieved
by utilizing a mechanism whereby some of the drug
in the adhesive was maintained in a crystalline
state while the rest was kept in a dissolved state.
This proprietary technology was subsequently applied
in the manufacture of other adhesive tapes.
In order to commercialize this product,
however, the company first had to develop advanced
processing technology. In the transdermal patch
manufacturing process, it was necessary to maintain
the thickness of the adhesive layer at µ20
(0.02mm). Because the product was to be used in
medical applications there could be no variation
in quality and at the time of manufacture it was
necessary to control tape thickness to within ±2µm
(0.002mm).
It is no exaggeration to say that precision
coating technology is the real secret behind the
successfully commercialization of this product.
In order to achieve goals it is necessary to
think a lot and then to translate the ideas that
come into action, and to repeat this process time
and time again. Basically, manufacturing is a process
that requires you to get your hands dirty and involves
much sweat and tears. There is nothing glamorous
about it at all. That is probably one of the reasons
that success, when it eventually comes, is particularly
sweet.
At times it may seem as though you
are facing a brick wall, but when you get off course
you just have to take the initiative and try something
else. Nothing gets solved sitting at a desk.
World-first products do not suddenly
appear as a result of some revolutionary idea.
The development of Hokunalin® Tape teaches us much
about the importance of continually trying out
various ideas and combinations.
Footer Area